glp 1/gip agonist Understand GLP-1/GIP Dual Tirzepatide and Its Effect on Current Weight Loss Therapy Effects, working principles and target

The original development partner, Janssen Pharmaceuticals, has handed back the license for efinopegdutide to the original developer, Hanmi Pharmaceutical, but the license has been taken up by Merck to be developed as a once weekly treatment for NAFLD

The Cardiovascular Biology of Glucagon-like Peptide-1

Gastroenterology 143, 765776.e3

Neuromuscul Disord 30(6):492502 Giovarelli M, Zecchini S, Casati SR, Lociuro L, Gjana O, Mollica L et al (2025) The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery

Some early studies have even shown that people on these medicines lost less brain tissue and had a slower drop in their thinking skills

The WHO estimates that more than 1 billion people worldwide are living with obesity, a condition that significantly increases the risk of cardiovascular disease, type 2 diabetes, cancer, and premature mortality